BIOCHEMISTRY

 

 

Publication Record

 

Bazarbachi, A., M. El-Sabban, R. Nasr, F. Quignon, C. Awaraji, J. Kersual, L. Dianoux, J. Haidar, O. Hermine, and H. De The. 1999. Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in HTLV-I tranformed cells. Blood 93 (1):278–283.

Bazarbachi, A., and O. Hermine. 2001. Treatment of adult T cell leukemia/lymphoma: Current strategy and future perspectives. Virus Research.

Bazarbachi, A., R. Nasr, M. El-Sabban, A. Mahe, R. Mahieux, A. Gessain, N. Darwiche, G. Dbaibo, J. Kersual, Y. Zermati, L. Dianoux, M. Chelbi-Alix, H. De The, and O. Hermine. 2000. Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/Lymphoma. Leukemia 14 (4):299–306.

 

Bou-Moglabey, Y., R. Kircheisen, M. Seoud, N. El-Mogharbel, I. Van den Veyyer, and R.  Slim. 1999. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Human Molecular Genetics 8 (4):667–671.

Cilio, M. R., A. R. Bolanos, Z. Liu, R. Schmid, Y. Yang, C. E. Stafstrom, M. A. Mikati, and G. L. Holmes. 2000. Anticonvulsant action and long-term effects of gabapentin in the immature brain. Neuropharmacology 40 (1):139–147.

Darwiche, N., M. El-Sabban, R. Bazzi, R. Nasr, S. Al Hashimi, O. Hermine, H. De The, and A. Bazarbachi. 2001. Retinoic acid dramatically enhances the arsenic trioxide induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I transformed cells. The Hematology Journal.

Darwiche, N., L. Freeman, and A. Strunnikov. 1999. Characterization of the components of the putative mammalian sister chromatid cohesion complex. Gene.

DeAngelis, M. M., T. L. McGee, B. J. B. Keats, R. Slim, E. L. Berson, and T. P. Dryja. 2001. Two families from New England with Usher syndrome type 1C with distinct haplotypes. American Journal of Ophtalmology.

El-Sabban, M., R. Nasr, G. Dbaibo, O. Hermine, N. Abboushi, F. Quignon, J. C. Ameisen, F. Bex, H. De The, and A. Bazarbachi. 2000. Arsenic/interferon-alpha triggered apoptosis in HTLV-I tranformed cells is associated with tax downregulation and reversal of NF-kB activation. Blood 96 (8):2849–2855.

Helwani, M. N., M. Seoud, L. Zahed, G. Zaatari, A. Khalil, and R. Slim. 1999. Familial case of recurrent hydatidiform molar pregnancies with biparental genomic contribution. Human Genetics 105 (1–2):112–115.

Kreydiyyeh, S., J. Usta, and R. Copti. 2000. Effect of cinnamon and clove and some of their constituents on the Na+/K+ ATPase activity and alanine absorption in the rat jejunum. Food and Chemical Toxicology 38 (9):755–762.

Kreydiyyeh, S., J. Usta, I. Kaouk, and R. Al-Sadi. 2001. The mechanism underlying the laxative properties of parsley extract. Phytomedicine.

Marlin, S., S. Blanchard, R. Slim, D. Lacombe, F. Denoyelle, J. L. Alessandri, E.  Calzolari, V. Droun-Garraud, F. G. Ferraz, A. Fourmaintraux, N. Philip, J. E.  Toublanc, and C. Petit. 1999. Townes-Brocks syndrome: Defection of a SALLI mutation hot spot and evidence for a position effect in one patient. Human Mutation 14 (5):377–386.

Matar, G., M. Fayad, and M. A. Mikati. 1999. A two-step protocol for the identification of the etiology of bacterial meningitis in cerebrospinal fluid by PCR-amplification of the 16S ribosomal RNA gene. Eastern Journal of Medicine.

Matar, G. M., M. Fayad, V. A. Khoudoud, and M. A.  Mikati. 2000. Herpes simplex encephalitis cases with variable or unusual clinical symptoms confirmed by PCR-amplification of the DNA polymerase gene. Eastern Journal of Medicine.

Megarbane, A., N. Waked, E. Chouery, Y. B. Moglabey, N. Saliba, E. Mornet, J. L. Serre, and R. Slim. 2001. Micocephaly, cutis verticis gyrata of the scalp, retinitis pigmentosa, cataracts, sensorineural deafness, and mental retardation in two brothers. American Journal of Medical Genetics 98 (3):244–249.

Mikati, M. A., S. Tarif, L. Lteif, and M. A. Jawad. 2001. Time sequence and types of memory deficits after experimental status epilepticus. Epilepsy Research 43 (2):97–101.

Mikati, M. A., S. Werner, A. Gatt, Z. Liu, A. Rahmeh, and R. Rachid. 1999. Consequences of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor blockade during status epilepticus in the developing brain. Developmental Brain Research 113 (1–2):139–142.

Ogretmen, B., D. Schady, J. Usta, R. Wood, J. Krakeva, C. Luberto, H. Birbes, Y. Hannun, and L. Obeid. 2001. Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells. Journal of Biological Chemistry 276 (27):24901–24910.

Shamseddine, A., A. Taher, H. Jaafar, J. H. Haidar, R. Nasr, V. Arzoumanian, Z. Salem, and A. Bazarbachi. 2000. Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I. Euoropean Journal of Haematology 65 (3):207–209.

Taher, A., I. Khalil, A. Shamseddine, F. El-Ahdab, and A. Bazarbachi. 2001. High prevalence of factor V leiden mutation among healthy individuals and patients with deep venous thrombosis  in Lebanon: Is Eastern Mediterranean region the primary focus of this mutation? Thrombosis and Haemostasis 86 (2):723–724.

Verpy, E., M. Leibovici, I. Zwaenepoel, X. Z. Liu, A. Gal, N. Salem, A. Mansour, S.  Blanchard, I. Kobayashi, B. J. B. Keats, R. Slim, and C. Petit. 2000. Defect in harmonin, a PDZ domain-containing protein, expressed in the inner ear sensory hair cells, underlies Usher syndrome 1C. Nature Genetics 26 (1):51–55.

 

 

 

Abstracts, Conferences, and Proceedings

 

Abboushi, N., W. El-Assad, M. El-Sabban, A. Bazerbachi, J. Usta, and G. Dbaibo. March 2001. Ceramide inhibits NF-kB dependent interleukin-2 transcription. The American Society for Biochemistry and Molecular Biology Meeting, Orlando, Florida, USA.

Arnulf, B., J. Oddos, Y. Zermati, J. Kersual, A. Bazarbachi, and O. Hermine. February 2000. Etude de la proteine virale TAX sur les signaux de transduction du TGF-B. French Society of Hematology, Paris, France.

Basbous, J., H. Abi-Haidar, J. Nigmeh, R. Abou-Merhi, O. Hermine, A. Bazarbachi, and M. El-Sabban. December 2000. Adhesion and intercellular communication between HTLV-I-transformed cells and other neoplastic T-cell lymphocytes and vascular endothelium. American Society of Hematology, San Francisco, California, USA.

Bazarbachi, A., M. Abdallah, T. Nasr, W. El-Assaad, M. El-Sabban, and G. Dbaibo. December 1999. Involvement of the ceramide pathway in the cytotoxicity of arsenic trioxide and interferon alpha in HTLV-I transformed cells. American Society of Hematology, New Orleans, Louisiana, USA.

Bazzi, H., S. Al-Maalouf, E. Hatoum, H. Gali-Muhtasib, and N. Darwiche. November 2000. Retinoic acid inhibits early vitamin A deficiency induced by ultraviolet irradiation of primary mouse keratinocytes. Proceedings of the 14th Science Meeting, Beirut, Lebanon.

Bazzi, R., R. Nasr, M. El-Sabban, A. Bazarbachi, and N. Darwiche. November 1999. Retinoic acid receptor alpha status determines the apoptotic response of HTLV-I transformed cells to the synergistic combination of retinoic acid and arsenic trioxide treatment. Proceedings of the 13th Science Meeting, Beirut, Lebanon.

Darwiche, N., M. El-Sabban, R. Bazzi , R. Nasr, H. De The, and A. Bazarbachi. January 2000. Retinoic acid dramatically enhances the arsenic trioxide induced cell cycle arrest and apoptosis in retinoic acid receptor alpha positive human T-cell leukemia virus type-I transformed cells. Cell and Molecular Biology Keystone Symposium: Cancer, Cell Cycle and Therapeutics, Steamboat Springs, Colorado, USA.

Darwiche, N., E. Hatoum, J. Khoury, and M. El-Sabban. January 2001. Introduction of retinoic acid receptors alpha and gamma into epidermal cell lines causes retinoic acid-induced growth arrest. Cell and Molecular Biology Keystone Symposium, The Molecular Basis of Cancer: Signaling to Cell Growth and Death, Taos, New Mexico, USA.

Darwiche, N., M. Sabban, R. Bazzi, R. Nasr, O. Hermine, H. De The, and A. Bazarbachi. December 2000. Retinoic acid and arsenic trioxide combination induces cell cycle arrest and apoptosis and downregulates tax in RAR alpha positive HTLV-I transformed cells. American Society of Hematology, San Francisco, California, USA.

El-Sabban, M., R. Nasr, G. Dbaibo, O. Hermine, N. Abboushi, F. Bex, H. De The, and A. Bazarbachi. May 2000. Arsenic/interferon-alpha triggered apoptosis in HTLV-I transformed cells is associated  with Tax downregulation and reversal of NF-kB activation. HTLV European Research Network, Postdam, Germany.

El-Sabban, M., R. Nasr, G. Dbaibo, O. Hermine, F. Bex, H. De The, and A. Bazarbachi. December 1999. Arsenic trioxide and alpha interferon combination downregulates Tax and targets the NF-kB pathway in HTLV-I transformed cells. American Society of Hematology, New Orleans, Louisiana, USA.

Hatoum, E., J. Khoury, M. El-Sabban, and N. Darwiche. November 2000. Introduction of retinoic acid receptors alpha and gamma into epidermal cell lines causes retinoic acid-induced growth arrest. Proceedings of the 14th Science Meeting, Beirut, Lebanon.

Hermine, O., H. Dombret, J. Poupon, B. Arnulf, G. Damaj, F. Lefrere, P. Rousselot, A. Tibbi, S. Solbes-Latourettes, J. P. Fermand, J. C. Brouet, and A. Bazarbachi. December 2000. Phase II trial of arsenic trioxide (As203) and combination of alpha interferon (INF) and As203 in patients with relapsed/refractory adult T cell leukemia (ATL). American Society of Hematology, San Francisco, California, USA.

Mikati, M. October 1999. Channelopathies: Implications on the pathophysiology, classification, and therapy of migraine and epilepsy. Syrian Pediatric Society Annual Meeting, Damascus, Syria.

———. April 2001. Effects of status epilepticus on the developing brain. The Annual Conference of Pediatrics Department, Cairo, Eygpt.

———. April 2001. Pathophysiology of epilepsy. Annual Congress of the Jordanian Neurology Society, Amman, Jordan.

Mikati, M. A., A. Rahmeh, F. Farhat, G. Dbaibo, and W. Assad. December 1999. Ceramide levels rise after status epilepticus  in the prepubescent and mature but not in the immature rat brain. American Epilepsy Society, San Diego, California, USA.

Mikati, M. A., A. Rahmeh, R. Kurdi, F. Farhat, E. Francis, G. Geha, W. Maraashli, and R. Kaddoura-Daouk. December 1999. Creatine has neuro-protective but not anti-seizure effects in the kainic acid seizure model. American Epilepsy Society, San Diego, California, USA.

Nakkash, H., K. Bajakian, S. Kreydiyyeh, and J. Usta. December 1999. The inhibitory effect of food spices on copper stimulated adenosine triphosphatase activity. The Third Annual Meeting of the Association of Colleges of Pharmacy in the Arab World, Tanta, Egypt.

Nasr, R., N. Darwiche, H. De The, and A. Bazarbachi. December 2000. Retinoic acid increases retinoid X receptor DNA binding activity despite the degradation of retinoid receptor proteins in HTLV-I transformed cells. American Society of Hematology, San Francisco, California, USA.

Nasr, R., M. El-Sabban, J. Basbous, R. Abou-Merhi, F. Bex, O. Hermine, H. De The, and A. Bazarbachi. December 2000. Arsenic/interferon-alpha triggered apoptosis in HTLV-I transformed cells is associated with proteasome mediated tax degradation and reversal of NF-kB activation. American Society of Hematology, San Francisco, California, USA.

Usta, J., S. El-Bawab, Z. Szulc, Y. Hannun, and A. Bielawska. March 2001. Structure-function relationship of ceramide analogues on rat brain alkaline. Ceramidase Activity Faseb Meeting, Orlando, Florida, USA.

 

 

Graduate Theses and Projects

 

El-khoury, J. Kh. February 2000. Regulation of neoplastic keratinocyte proliferation and cell cycle control by retinoic acid receptor alpha. I. Durr and N. Darwiche.

Hatoum, E. January 2001. Molecular mechanisms of cell cycle control in retinoic acid receptor gamma-transduced neoplastic epidermal cell lines. I. F. Durr and N. Darwiche.

 

 

Research Projects

 

The mechanism of action and development of novel therapies for HTLV-I associated adult T-cell leukemia/lymphoma (ATL)

ATL is a malignancy of activated T cells resistant to chemotherapy. The viral transactivator protein, Tax, plays a critical role in HTLV-I-induced transformation and apoptosis resistance by inducing IkB-Kinase (IKK)-mediated IkB alpha phosphorylation and proteasomal degradation, resulting in sustained activation of the NF-kB pathway.  We recently showed that As and IFN synergies induce cell cycle arrest and apoptosis in ATL cells.  We demonstrated that As/IFN induces the degradation of Tax, associated with an upregulation of IkB-alpha, resulting in cytoplasmic retention of the RelA subunit of NF-kB and a sharp decrease in RelA DNA-binding NF-kB complexes. Due to the pivotal role Tax plays in HTLV-I-induced transformation, its down-regulation by As/IFN may account for cell death through inactivation of the NF-kB pathway. We also showed that ATRA synergize with As to induce cell cycle arrest and apoptosis RAR-alpha positive ATL cells. In this project, we aim to decipher the mechanism of action of As/IFN and ATRA therapies in ATL derived cells. Bazarbachi, A., M. El-Sabban, G. Dbaibo, and N. Darwiche.

Supported by AUB Medical Practice Plan, URB, LNCSR, Cedres, and Eli Lilly
Completed or in progress at AUB

 

Molecular mechanisms of ceramide-mediated telomerase inhinition in the A549 human lung adenocarcinoma cell line

Submitted to Journal of Biological Chemistry.  Besim, O.*, M. Jacqueline, J. Usta*, Y. Hannun*, and L. Obeid*.

 

Supported by AUB and Medical University of South Carolina, USA.

 

The role of retinoic acid receptor alpha in the combined retinoic acid and arsenic treatment of adult T-cell leukemic (ATL) cells

Adult T-cell leukemia (ATL) is an aggressive malignancy of mature activated T cells that is caused by human T-cell leukemia virus type I (HTLV-I).  Recently, we investigated the combined effects of retinoic acid (RA) and arsenic (As) treatments on the growth of HTLV-I transformed cells (HuT-102 and MT-2). We showed that, while both cell lines were resistant to RA treatment, the combination RA/As induced a highly synergistic effect only on HuT-102 cells. The combination treatment resulted in a dramatic inhibition of cell proliferation and induction of massive apoptosis in HuT-102 cells. Retinoid receptor protein analysis showed that both cell lines express RXRalpha proteins, RARalpha protein levels are undetectable in MT-2 cells but highly expressed in HuT-102 cells.  We would like to test our hypothesis linking the successful combination treatment of RA and As in ATL to the presence of RARalpha using retroviral-mediated gene transfer methods. Darwiche, N. (PL).

Supported by URB
Completed or in progress at AUB

 

Combined retinoic acid and arsenic treatment of adult T-cell leukemic (ATL) cells:  Effects on cell cycle control and apoptosis regulation of neoplastic keratinocyte proliferation and cell cycle control by retinoid receptors

Adult T-cell leukemia (ATL) is an aggressive peripheral T-cell neoplasm caused by human T-cell leukemia virus type I (HTLV-I).  Multiple chemotherapy combinations are used for the treatment of ATL patients.  Unfortunately, the results are disappointing with a mean survival time of less than 8 months mainly due to acquired resistance.  We will investigate the effects of retinoic acid (RA) and arsenic (As) on different cellular parameters, namely cytotoxicity, proliferation, cell cycle analysis, and apoptosis.  If RA and As combination treatment results in the induction of apoptosis in ATL derived cells, we will also study the induction of the different apoptotic pathways and their relationship to retinoid receptor signaling.  We will determine the retinoid receptor profile in RA- and As-treated cells in an attempt to understand whether the different treatments enhance retinoid responsiveness in these cells. Darwiche, N., (PL), A. Bazarbachi, and M. El-Sabban.
 
Supported by URB and LNCSR
Completed or in progress at AUB

 

Regulation of neoplastic keratinocyte proliferation and cell cycle control by retinoid receptors

Retinoids are essential for normal epidermal cell growth and differentiation.  They are widely used in the prevention, as well as treatment of, several skin disorders and cancers in humans.  Most of the effects of retinoids are mediated by two families of nuclear retinoid receptors, namely, RARs and RXRs, each consisting of the receptor types alpha, beta, and gamma.  Our studies indicate that retinoic acid receptors, RARalpha and RARgamma, are lost during skin tumor progression.  Furthermore, during transformation, decreased expression of RARalpha is closely linked to malignant conversion of skin tumors. Using combined in vitro and in vivo strategies, we will explore the relationship between RARs and neoplastic keratinocyte proliferation and cell cycle regulation.  This will include the use of RAR and RXR-selective ligands and retroviral constructs harboring normal RARalpha, RARgamma, and RAR dominant-negative mutants. Darwiche, N., (PL), and I. F. Durr.
 
Supported by Terry Fox Cancer Research Funds, Diana Tamari Sabbagh Fund, AUB Medical Practice Plan, and URB
Completed or in progress at AUB

 

Overexpression of retinoic acid receptors, alpha and gamma, in neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis

Retinoids are essential for normal epidermal differentiation and are used for the prevention and treatment of numerous skin disorders and cancers in humans.  In previous studies, we have shown that retinoic acid receptors (RARs), alpha and gamma, are down-regulated during skin tumor progression.  Our primary objective is to investigate the roles that RARalpha and RARgamma play in keratinocyte tumor cell proliferation.  Through retroviral gene transduction, we overexpressed RARalpha or RARgamma in neoplastic mouse epidermal cells.  Following retinoic acid (RA) treatment, RARalpha- and RARgamma-transduced cell lines exhibit a progressive, dose-dependent growth inhibition relative to the control LXSN cell lines.  Chromatin condensation, PARP cleavage, and a late upregulation and apparent cleavage of the squamous differentiation marker PKCeta are observed in both RARalpha- and RARgamma-transduced cells.  These results suggest that RARalpha and RARgamma enhance growth suppression and apoptosis of neoplastic epidermal keratinocytes.  We also showed that this growth inhibitory effect of both retinoid receptors in neoplastic keratinocytes may be achieved through distinct as well as overlapping mechanisms of cell cycle control. Submitted for publication. Darwiche, N. (PL), E. Hatoum, M. El-Sabban, J. Khoury, and S. H. Yuspa.

Supported by Terry Fox Cancer Research Funds, Diana Tamari Sabbagh Fund, AUB Medical Practice Plan, and URB
Completed or in progress at AUB

 

Molecular mechanisms of ceramide accumulation following up-regulation of the tumor suppressor P53

Both the tumor suppressor, p53, and ceramide have been implicated in the regulation of apoptosis. We recently showed that p53 functions "upstream" of ceramide in the genotoxic stress response leading to apoptosis. We found that p53 up-regulation leads to the gradual accumulation of cellular ceramide occurring over several hours. In this proposal, we investigated the signaling pathways and the molecular events by which p53 up-regulation results in ceramide accumulation. We also investigated the order by which the different genes become induced, or their proteins activated, in response to p53 and in relation to ceramide accumulation. In on-going studies, we plan to determine the biochemical pathways that are activated to generate ceramide. These studies will help us understand the molecular mechanisms by which these two stress responses, namely, p53 up-regulation and ceramide accumulation, are linked and may help in the discovery of future therapeutic targets in cancer and other diseases where apoptosis plays a major role. Dbaibo, G. (PL).

Supported by LNCSR, URB, AUB Medical Practice Plan, and Diana Tamari Sabbagh Fund, and Massabki Research Fund
Completed or in progress at AUB

 

The role of ceramide in modulating the expression of the growth factors Il-2, Il-15, and their receptors

Interleukin (IL)-2 and IL-15 play a pivotal role in initiating and potentiating the immune response. The receptors for IL-15 and IL-2 consist of three subunits: a unique alpha chain and shared beta and gamma chains. Expression of both receptors occurs via regulation of the expression of their alpha chains. Both interleukins and their receptors have been implicated in HTLV-1-associated adult T-cell leukemia and chronic lymphoproliferative disorders, where they play a role in survival and proliferation. In previous studies, we demonstrated that the sphingolipid breakdown product, ceramide, blocks the production of IL-2 by Jurkat T-cell leukemia cells with phorbol ester and PHA. We demonstrated that this inhibition was at the IL-2 gene transcription level, and that it was likely mediated by the inhibition of the transcription factor NF-kB. In this study, we plan to examine whether our findings extend to the IL-2a receptor chain, IL-15, and its receptor, all of which require NF-kB activation for proper transcription. Dbaibo, G. (PL), A. Bazarbachi, and N. Abboushi.

Supported by Alpha Omega Alpha
Completed or in progress at AUB

 

Mechanisms of programed cell death after status epilepticus

The goal of this study is to further investigate the mechanisms of post-SE cellular injury and the role of ceramide in those mechanisms. Mikati, M.

Supported by URB
Completed or in progress at AUB

 

Potential role of ceramide in status epilepticus related brain injury

The goal of this study is to investigate whether the demonstrated increases in ceramide are related to Status Epilepticus (SE)-associated neuronal injury.  Mikati, M.


Supported by Massabki Researh Fund

Completed or in progress at AUB

 

The effect of experimental status epilepticus on ceramide levels in the developing brain

The goal of this study is to investigate whether Status Epilepticus (SE) is followed by increases in ceramide levels, and whether there are differences in ceramide levels after SE in developmental stages. Mikati, M.

Supported by URB and National Council for Scientific Research
Completed or in progress at AUB

 


Copper transport into mitochondria: The role of a copper adenosine tri-phosphatase activity

A copper-stimulated ATPase (Cu++-ATPase) activity was described in isolated rat liver mitochondria. Whether this protein is involved in regulating the copper level in the mitochondria remains to be established. Isolated mitochondria will be treated with different copper concentrations, the uptake of which will be estimated by inductively coupled plasma (ICP-MS). Copper uptake will be optimized according to time, concentration, temperature, and pH. Preliminary data have identified sodium azide and eugenol as inhibitors of the Cu++ ATPase stimulated activity. The effects of these inhibitors on copper transport will be determined as well. Usta, J., and N. Cortas.


Supported by AUB Medical Practice Plan
In progress at AUB

 

Profile of sphingolipid metabolizing enzymes in the mitochondria.

The discovery that cytochrome c, required for apoptosis, and BcL-2, an anti-apoptotic, are mitochondrial has placed the mitochondria at a central position in the study of apoptosis. Recent studies have shown that the purification of a non-lysosomal mitochondria-associated alkaline ceramidase from rat-brain, and partial purification of ceramide synthase from Bovine liver mitochondrial-enriched fraction, suggesting that the mitochondria is a possible site of sphingolipid metabolism.  So far neither the sphingolipid composition nor the profile of shingolipid metabolizing enzymes in the mitochondria are known.  Thus the objectives of this study are first, to quantify the level of ceramide, diacylgycerol, sphingosine, and sphingomyelin in the inner, outer mitochondrial membranes as well as associated membranes, and second, to determine the profile of sphingolipid metabolizing enzymes, both catabolic and anabolic, in the mitochondria, such as alkaline and acid ceramidase, ceramide synthase, glucocerebroside synthase, sphingomyelin synthase, and sphingomyelinase. Usta, J., and Y. Hannun (Medical University of South Carolina, USA).

Supported by AUB Medical Practice Plan
In progress at AUB

 

Effects of eugenol and cinnamaldehyde on mitochondrial functions

We have recently reported inhibition of Na+/K+ATPase by eugenol and cinnamaldehyde the main components of clove and cinnamaldehyde, respectively. Contrary to their effect on Na+/K+ATPase, they stimulated mitochondrial F0 F1 ATPase activity, the consequence of which is reduction of the cellular energy level (ATP). We propose mitochondria as a potential target for spices action. Hence, the objective of this study is 1) to determine the effect of eugenol and cinnamaldehyde on complex-I and complex-II, the main entry sites of NADH and FADH2 into the respiratory chain, and 2) to identify whether the increase in the hydrolysis of ATP is due to an effect on the mitochondrial membrane potential. Submitted to Food and Chemical Toxicology. Usta, J., and S. Kreydiyyeh.

Supported by AUB Medical Practice Plan and URB
Completed at AUB

 

Direct effect of sphingosine and ceramide on the mitochondrial functions

It is well established that ceramide is an endogenous regulator of apoptosis in many different cancer cells and in response to many cytotoxic and chemotherapeutic agents. Preliminary experiments, directing bSMase at different places in the cell were ineffective in the case of nucleus and cytosol, but resulted in cell death when directed at mitochondria.  This suggests that generation of ceramide in the mitochondria may trigger the apoptotic signal. This study attempts to evaluate the mechanisms underlying the role of ceramide in induced mitochondrial apoptosis. The direct effect of different chain length ceramide (C2, C6, C12, C16) and sphingosine on mitochondrial functions will be determined, including the integrity of the membrane potential and the activity of NADH oxidase succinate dehydrogenase, cytochrome c reductase, and cytochrome oxidase. Usta, J., and L. Obeid (Medical University of South Carolina, USA).

Supported by AUB Medical Practice Plan
Completed or in progress at AUB

 

Inhibitors of mitochondrial ceramidase biochemistry


Submitted to Biochemistry. Usta, J., S. El-Bawab, P. Roddy, Z. Szulc, Y. Hannun, and A. Bielawska.

 

Supported by AUB and Medical University of South Carolina, USA.